Related Experiment Video
Updated: Mar 27, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Harnessing artificial intelligence: Revolutionizing clinical care for Parkinson's disease
1Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
None:
As the use of artificial intelligence (AI) in healthcare becomes more pervasive, its application in the clinical care for those with Parkinson's disease (PD) presents exciting opportunities to improve the timeliness and accuracy of diagnosis and to optimize treatment. Perhaps more than many other neurological conditions, PD lends itself to the creation of rich data from which AI can surface actionable insights that hold the potential to revolutionize PD care in a personalized manner. For direct clinical care, AI has the potential to contribute to initial diagnosis, disease subtyping, symptom identification and severity assessment, progression monitoring, and treatment management. With patients and clinicians informing AI and contributing to its methods of deployment, an enormous opportunity exists to open up access to expert-level care to many more people.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment
EPS and iPS Cells in Disease Research
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neural Regulation

